危重病性肌病和神经病综述
Review of Critical Illness Myopathy and Neuropathy.
作者信息
Shepherd Starane, Batra Ayush, Lerner David P
机构信息
Department of Neurology, Brigham and Women's Hospital & Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
出版信息
Neurohospitalist. 2017 Jan;7(1):41-48. doi: 10.1177/1941874416663279. Epub 2016 Aug 23.
Abstract
Critical illness myopathy (CIM) and neuropathy are underdiagnosed conditions within the intensive care setting and contribute to prolonged mechanical ventilation and ventilator wean failure and ultimately lead to significant morbidity and mortality. These conditions are often further subdivided into CIM, critical illness polyneuropathy (CIP), or the combination-critical illness polyneuromyopathy (CIPNM). In this review, we discuss the epidemiology and pathophysiology of CIM, CIP, and CIPNM, along with diagnostic considerations such as detailed clinical examination, electrophysiological studies, and histopathological review of muscle biopsy specimens. We also review current available treatments and prognosis. Increased awareness and early recognition of CIM, CIP, and CIPNM in the intensive care unit setting may lead to earlier treatments and rehabilitation, improving patient outcomes.
摘要
危重病性肌病（CIM）和神经病在重症监护环境中诊断不足，会导致机械通气时间延长和脱机失败，并最终导致显著的发病率和死亡率。这些病症通常进一步细分为CIM、危重病性多发性神经病（CIP）或两者合并的危重病性多神经肌病（CIPNM）。在本综述中，我们讨论了CIM、CIP和CIPNM的流行病学和病理生理学，以及诊断方面的考虑因素，如详细的临床检查、电生理研究和肌肉活检标本的组织病理学检查。我们还综述了当前可用的治疗方法和预后情况。在重症监护病房环境中提高对CIM、CIP和CIPNM的认识并早期识别，可能会带来更早的治疗和康复，改善患者预后。
相似文献
1
Review of Critical Illness Myopathy and Neuropathy.危重病性肌病和神经病综述
Neurohospitalist. 2017 Jan;7(1):41-48. doi: 10.1177/1941874416663279. Epub 2016 Aug 23.
3
Interventions for preventing critical illness polyneuropathy and critical illness myopathy.预防危重病性多发性神经病和危重病性肌病的干预措施。
Cochrane Database Syst Rev. 2014 Jan 30;2014(1):CD006832. doi: 10.1002/14651858.CD006832.pub3.
4
Critical illness polyneuromyopathy (CIPNM); rehabilitation during critical illness. Therapeutic options in nursing to promote recovery: a review of the literature.危重病性多发神经病（CIPNM）；危重病期间的康复。护理中促进恢复的治疗选择：文献复习。
Intensive Crit Care Nurs. 2010 Dec;26(6):353-62. doi: 10.1016/j.iccn.2010.08.008.
5
Clinical review: Critical illness polyneuropathy and myopathy.临床综述：危重病性多发性神经病和肌病
Crit Care. 2008;12(6):238. doi: 10.1186/cc7100. Epub 2008 Nov 25.
6
Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review.危重病性多发性神经病和肌病患者的恢复和长期功能结局：范围综述。
BMC Neurol. 2022 Feb 11;22(1):50. doi: 10.1186/s12883-022-02570-z.
7
Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis.危重病性多发性神经病和肌病：临床特征、危险因素及预后
Eur J Neurol. 2006 Nov;13(11):1203-12. doi: 10.1111/j.1468-1331.2006.01498.x.
8
Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.危重病性多发性神经病和肌病：导致肌肉无力和瘫痪的主要原因。
Lancet Neurol. 2011 Oct;10(10):931-41. doi: 10.1016/S1474-4422(11)70178-8.
9
Electrophysiological Screening to Assess Foot Drop Syndrome in Severe Acquired Brain Injury in Rehabilitative Settings.康复环境中评估重度获得性脑损伤所致足下垂综合征的电生理筛查
Biomedicines. 2024 Apr 16;12(4):878. doi: 10.3390/biomedicines12040878.
10
Neurophysiological study of critical illness polyneuropathy and myopathy in mechanically ventilated children; additional aspects in paediatric critical illness comorbidities.机械通气患儿危重病性多发性神经病和肌病的神经生理学研究；小儿危重病合并症的其他方面。
Eur J Neurol. 2018 Jul;25(7):991-e76. doi: 10.1111/ene.13649. Epub 2018 Apr 30.
引用本文的文献
1
Author Response: Rectus Femoris Cross-sectional Area Remains a Vague Outcome Predictor of Polyradiculitis as Long as Not All Influencing Factors are Considered.作者回应：只要未考虑所有影响因素，股直肌横截面积仍是多神经根炎的一个模糊的预后预测指标。
Indian J Crit Care Med. 2025 Jun;29(6):540-541. doi: 10.5005/jp-journals-10071-24978. Epub 2025 Jun 5.
2
Impact of COVID-19 on Diaphragmatic Function: Understanding Multiorgan Involvement and Long-Term Consequences.2019冠状病毒病对膈肌功能的影响：了解多器官受累情况及长期后果。
J Clin Med. 2024 Oct 29;13(21):6493. doi: 10.3390/jcm13216493.
3
Advances in nutritional metabolic therapy to impede the progression of critical illness.阻碍危重病进展的营养代谢治疗进展。
Front Nutr. 2024 Jul 5;11:1416910. doi: 10.3389/fnut.2024.1416910. eCollection 2024.
4
Outcome, predictors and longitudinal trajectories of subjects with critical illness polyneuropathy and myopathy (CINAMOPS): study protocol of an observational cohort study in a clinical and post-clinical setting.危重病相关性肌神经病和肌病（CINAMOPS）患者的结局、预测因素和纵向轨迹：一项临床和临床后环境下观察性队列研究的研究方案。
BMJ Open. 2024 Apr 25;14(4):e083553. doi: 10.1136/bmjopen-2023-083553.
5
Insights into neurological dysfunction of critically ill COVID-19 patients.对危重症新冠病毒疾病患者神经功能障碍的见解
Trends Anaesth Crit Care. 2021 Feb;36:30-38. doi: 10.1016/j.tacc.2020.09.005. Epub 2020 Sep 15.
6
Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized Crossover Clinical Trial.新冠后疾病患者的功能限制和运动不耐受：一项随机交叉临床试验。
JAMA Netw Open. 2024 Apr 1;7(4):e244386. doi: 10.1001/jamanetworkopen.2024.4386.
7
Lower serum cholesterol levels as a risk factor for critical illness polyneuropathy: a matched case-control study.血清胆固醇水平降低作为危重病多发性神经病的危险因素：一项配对病例对照研究。
Sci Rep. 2023 Nov 21;13(1):20405. doi: 10.1038/s41598-023-47232-3.
8
Evaluating the Efficacy of ChatGPT in Navigating the Spanish Medical Residency Entrance Examination (MIR): Promising Horizons for AI in Clinical Medicine.评估ChatGPT在应对西班牙医学住院医师入学考试（MIR）中的效果：人工智能在临床医学中的广阔前景。
Clin Pract. 2023 Nov 20;13(6):1460-1487. doi: 10.3390/clinpract13060130.
9
The Loss of Temporal Muscle Volume is Associated with Poor Outcome in Patients with Subarachnoid Hemorrhage: An Observational Cohort Study.颞肌体积丢失与蛛网膜下腔出血患者的不良预后相关：一项观察性队列研究。
Neurocrit Care. 2023 Aug;39(1):198-206. doi: 10.1007/s12028-023-01751-z. Epub 2023 Jun 12.
10
Neuromuscular Disorders Associated With COVID-19.与新型冠状病毒肺炎相关的神经肌肉疾病
Neurosci Insights. 2023 May 25;18:26331055231176251. doi: 10.1177/26331055231176251. eCollection 2023.
本文引用的文献
1
Clinical review: intensive care unit acquired weakness.临床综述：重症监护病房获得性肌无力
Crit Care. 2015 Aug 5;19(1):274. doi: 10.1186/s13054-015-0993-7.
2
Physical rehabilitation for critical illness myopathy and neuropathy.危重病性肌病和神经病的物理康复
Cochrane Database Syst Rev. 2015 Mar 4;2015(3):CD010942. doi: 10.1002/14651858.CD010942.pub2.
3
Critical illness polyneuropathy and myopathy: a systematic review.危重病性多发性神经病和肌病：系统评价。
Neural Regen Res. 2014 Jan 1;9(1):101-10. doi: 10.4103/1673-5374.125337.
4
Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial.耐受宏量营养素缺乏对 ICU 获得性肌无力发展的影响：EPaNIC 试验的亚分析。
Lancet Respir Med. 2013 Oct;1(8):621-629. doi: 10.1016/S2213-2600(13)70183-8. Epub 2013 Sep 10.
5
Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial.富含IgM的静脉注射免疫球蛋白早期治疗不能减轻多器官功能衰竭和全身炎症反应综合征/脓毒症患者的危重病性多发性神经病和/或肌病：一项前瞻性、随机、安慰剂对照、双盲试验。
Crit Care. 2013 Oct 2;17(5):R213. doi: 10.1186/cc13028.
6
Electrophysiology of neuromuscular disorders in critical illness.危重病患者神经肌肉疾病的电生理学。
Muscle Nerve. 2013 Mar;47(3):452-63. doi: 10.1002/mus.23615. Epub 2013 Feb 6.
7
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.拯救脓毒症运动：严重脓毒症和脓毒性休克管理国际指南，2012 年。
Intensive Care Med. 2013 Feb;39(2):165-228. doi: 10.1007/s00134-012-2769-8. Epub 2013 Jan 30.
8
Sonographic evaluation of the diaphragm in critically ill patients. Technique and clinical applications.超声评估危重症患者的膈肌：技术与临床应用。
Intensive Care Med. 2013 May;39(5):801-10. doi: 10.1007/s00134-013-2823-1. Epub 2013 Jan 24.
9
Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.重症监护病房（ICU）肌肉萎缩的潜在机制及被动机械负荷的影响。
Crit Care. 2012 Oct 26;16(5):R209. doi: 10.1186/cc11841.
10
Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.危重病性多发性神经病和肌病：导致肌肉无力和瘫痪的主要原因。
Lancet Neurol. 2011 Oct;10(10):931-41. doi: 10.1016/S1474-4422(11)70178-8.
Zotero 插件